This is for research purposes only, not for human consumption
Research library

Peptide Research

CJC-1295 (No DAC) + Ipamorelin

Also known as Mod GRF (1-29) + Ipamorelin

Blend pairing a GHRH analog with a selective ghrelin-receptor secretagogue in a single research vial.

Classification
Peptide blend: GHRH analog + GHS-R agonist
Supplied form
Lyophilized blend, research vial
Storage
Lyophilized powder is typically stored refrigerated or frozen and protected from light. Prepared solutions are generally kept refrigerated and handled under standard laboratory practice.
Solubility
Both components are water soluble and prepared as a single laboratory solution.

What the blend is

CJC-1295 without DAC (also called Mod GRF 1-29) is a short-acting GHRH analog. Ipamorelin is a selective growth hormone secretagogue receptor agonist. The blend supplies both in one vial.

Research context

The two pathways are frequently studied in combination because they act on distinct receptors within the growth hormone axis, allowing researchers to examine complementary signalling.

Handling in the laboratory

Because the vial contains a blend, the labelled milligram total covers both peptides. Concentration math applies to the vial as supplied.

Research disclaimer

Supplied for legitimate laboratory research purposes only. Not for human or veterinary use. Lucent Life does not provide medical advice, diagnosis, treatment, or dosing instructions.

Catalog listings

Frequently asked

What does 'No DAC' mean?

DAC (Drug Affinity Complex) is an albumin-binding modification that extends half-life. The No-DAC form omits it, giving a shorter-acting profile in the literature.

More reference pages

Research disclaimer: This page is a laboratory reference summary of published research context. Products supplied by Lucent Life are reference materials for in-vitro laboratory research only — not drugs, supplements, or products for human consumption.